|3rd February 2020||Jerry J Jasinowski||526,316||Grant/award etc.||$0.19||$100,000.04|
|27th January 2020||Linda F Powers||220,000||Open or private sale||$4.60||$1,012,000.00|
|3rd June 2019||Linda F Powers||10,000||Open or private purchase||$6.00||$60,000.00|
|8th May 2019||Linda F Powers||61,667||Open or private purchase||$9.00||$555,003.00|
|28th December 2018||Linda F Powers||804,146||Open or private sale||$0.17||$136,704.82|
|27th December 2018||Linda F Powers||3,558,639||Open or private sale||$0.17||$604,968.63|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
Northwest Biotherapeutics, Inc. is a clinical stage biotechnology company. The firm engages in the development of cancer vaccines designed to treat solid tumor cancers. It also offers a platform technology for DCVax dendritic cell-based vaccines.